GB0500643D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB0500643D0
GB0500643D0 GBGB0500643.2A GB0500643A GB0500643D0 GB 0500643 D0 GB0500643 D0 GB 0500643D0 GB 0500643 A GB0500643 A GB 0500643A GB 0500643 D0 GB0500643 D0 GB 0500643D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0500643.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Priority to GBGB0500643.2A priority Critical patent/GB0500643D0/en
Publication of GB0500643D0 publication Critical patent/GB0500643D0/en
Priority to EP06701354.0A priority patent/EP1858544B1/en
Priority to JP2007550830A priority patent/JP2008526935A/ja
Priority to US11/795,135 priority patent/US20080139478A1/en
Priority to AU2006205696A priority patent/AU2006205696C1/en
Priority to PCT/GB2006/000051 priority patent/WO2006075138A2/en
Priority to HK07113291.2A priority patent/HK1105366B/en
Priority to EP10182870A priority patent/EP2332566A1/en
Priority to CA002594798A priority patent/CA2594798A1/en
Priority to US13/317,030 priority patent/US20120238505A1/en
Priority to JP2012165481A priority patent/JP2012211185A/ja
Priority to US14/487,838 priority patent/US20150218222A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GBGB0500643.2A 2005-01-13 2005-01-13 Medicaments Ceased GB0500643D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB0500643.2A GB0500643D0 (en) 2005-01-13 2005-01-13 Medicaments
CA002594798A CA2594798A1 (en) 2005-01-13 2006-01-06 Il-10 related peptides for wound healing
AU2006205696A AU2006205696C1 (en) 2005-01-13 2006-01-06 IL-10 related peptides for wound healing
JP2007550830A JP2008526935A (ja) 2005-01-13 2006-01-06 創傷治癒のためのｉｌ−１０関連ペプチド
US11/795,135 US20080139478A1 (en) 2005-01-13 2006-01-06 IL-10 Related Peptides For Wound Healing
EP06701354.0A EP1858544B1 (en) 2005-01-13 2006-01-06 Il-10 related peptides for wound healing
PCT/GB2006/000051 WO2006075138A2 (en) 2005-01-13 2006-01-06 Il-10 related peptides for wound healing
HK07113291.2A HK1105366B (en) 2005-01-13 2006-01-06 Il-10 related peptides for wound healing
EP10182870A EP2332566A1 (en) 2005-01-13 2006-01-06 IL-10 related peptides for wound healing
US13/317,030 US20120238505A1 (en) 2005-01-13 2011-10-07 Medicaments
JP2012165481A JP2012211185A (ja) 2005-01-13 2012-07-26 創傷治癒のためのｉｌ−１０関連ペプチド
US14/487,838 US20150218222A1 (en) 2005-01-13 2014-09-16 Medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0500643.2A GB0500643D0 (en) 2005-01-13 2005-01-13 Medicaments

Publications (1)

Publication Number Publication Date
GB0500643D0 true GB0500643D0 (en) 2005-02-23

Family

ID=34224534

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0500643.2A Ceased GB0500643D0 (en) 2005-01-13 2005-01-13 Medicaments

Country Status (7)

Country Link
US (3) US20080139478A1 (enExample)
EP (2) EP1858544B1 (enExample)
JP (2) JP2008526935A (enExample)
AU (1) AU2006205696C1 (enExample)
CA (1) CA2594798A1 (enExample)
GB (1) GB0500643D0 (enExample)
WO (1) WO2006075138A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments
KR20150072458A (ko) * 2006-11-15 2015-06-29 코다 테라퓨틱스, 인크. 상처 치유를 위한 개선 방법 및 조성물
CA2767132C (en) 2009-07-06 2017-06-20 Astrazeneca Ab Intermediates and processes for the preparation of 4-(acetylamino))-3-[(4-chloro-phenyl)thio]-2-methyl-1h-indole-1-acetic acid
US20140112898A1 (en) * 2011-03-31 2014-04-24 President And Fellows Of Harvard College Unique population of regulatory t cells that regulate tissue regeneration and wound healing
KR20160003651A (ko) * 2013-03-14 2016-01-11 가부시끼가이샤 쓰리디 매트릭스 위장 폐색 예방용 물질
JP2016519108A (ja) 2013-04-18 2016-06-30 アルモ・バイオサイエンシーズ・インコーポレイテッド インターロイキン−１０を疾病及び疾患の治療に用いる方法
WO2014204816A2 (en) 2013-06-17 2014-12-24 Armo Biosciences, Inc. Method for assessing protein identity and stability
US10098929B2 (en) 2013-08-02 2018-10-16 Children's Hospital Medical Center Method of reducing scar formation in healing of dermal wounds by administering interleukin-10 and hyaluronan
CA2920679A1 (en) 2013-08-30 2015-03-05 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CN105848674A (zh) 2013-11-11 2016-08-10 阿尔莫生物科技股份有限公司 将白细胞介素-10用于治疗疾病和病症的方法
US10293043B2 (en) 2014-06-02 2019-05-21 Armo Biosciences, Inc. Methods of lowering serum cholesterol
CA2963989A1 (en) 2014-10-14 2016-04-21 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
CN107106655A (zh) 2014-10-22 2017-08-29 阿尔莫生物科技股份有限公司 使用白细胞介素‑10治疗疾病和病症的方法
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CN107847583A (zh) 2015-05-28 2018-03-27 阿尔莫生物科技股份有限公司 用于治疗癌症的聚乙二醇化白细胞介素‑10
EP3341012B1 (en) 2015-08-25 2025-07-30 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217857B1 (en) * 1989-06-28 2001-04-17 Schering Corporation Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof
US6159937A (en) * 1994-07-05 2000-12-12 Steeno Research Group A/S Immunomodulators
GB2304047A (en) 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
AU4385696A (en) * 1996-01-18 1997-08-11 Christian Gronhoj Larsen Synthetic il-10 analogues
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments

Also Published As

Publication number Publication date
US20150218222A1 (en) 2015-08-06
EP2332566A1 (en) 2011-06-15
AU2006205696A1 (en) 2006-07-20
AU2006205696C1 (en) 2012-01-19
US20080139478A1 (en) 2008-06-12
AU2006205696B2 (en) 2011-09-01
WO2006075138A2 (en) 2006-07-20
EP1858544A2 (en) 2007-11-28
EP1858544B1 (en) 2014-03-05
WO2006075138A3 (en) 2006-10-19
CA2594798A1 (en) 2006-07-20
JP2012211185A (ja) 2012-11-01
JP2008526935A (ja) 2008-07-24
HK1105366A1 (en) 2008-02-15
US20120238505A1 (en) 2012-09-20

Similar Documents

Publication Publication Date Title
GB0520794D0 (en) Inhaler
DE502006001600D1 (en) Pyrazolylcarboxanilide
DE602006017073D1 (en) Aspartylproteasehemmer
GB0519151D0 (en) Inhaler
AP2008004533A0 (en) Pharmaceutical combination
EP1871379A4 (en) CYANOARYLAMINE
EP1859828A4 (en) INHALER
GB0500643D0 (en) Medicaments
EP1862192A4 (en) INHALER
EP1871655A4 (en) TRIGGER OPERATION FOR SIDE DRIVE
ZA200804666B (en) Pharmaceutical combination
GB0511204D0 (en) Medicaments
GB0507003D0 (en) Therapeutic
GB0402491D0 (en) Medicaments
EP1865780A4 (en) MINI OVEN
GB0613031D0 (en) Medicaments
GB0403733D0 (en) Medicaments
EP1853258A4 (en) DRUGS
DE602006015303D1 (en) Lecknachweisflicken
TWI372053B (en) Combination drug
GB0512246D0 (en) Novel pharmaceutical
GB0518439D0 (en) Soother
GB0510091D0 (en) Inhaler
GB0514260D0 (en) Medicaments
GB0502541D0 (en) Medicament

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)